YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Laurus Labs

Laurus Labs

BSE: 540222|NSE: LAURUSLABS|ISIN: INE947Q01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 22, 15:56
613.30
11 (1.83%)
VOLUME 76,281
LIVE
NSE
Jun 22, 16:00
613.55
11.15 (1.85%)
VOLUME 1,502,285
News on Laurus Labs
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Laurus Labs: Foray into biotech adds new lever of growth; accumulate

9.45 am | 02 Dec 2020 |  Source: Moneycontrol.com

Efforts to diversify will open up new opportunities for Laurus Labs and make it move towards a higher-margin trajectory...

Laurus Labs says Richcore buy will help it become a leading biotech contract manufacturer

7.24 pm | 26 Nov 2020 |  Source: Moneycontrol.com

In an interview to Moneycontrol, Satyanarayana Chava, CEO of Laurus Labs, said Richore acquisition will help them leapfrog in biotech which is conside...

Buy Laurus Labs; target of Rs 390: ICICI Direct

9.34 pm | 04 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 390 in its research report dated October 30, 2020...

Accumulate Laurus Labs; target of Rs 400: Dolat Capital Market

4.57 pm | 03 Nov 2020 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Laurus Labs with a target price of Rs 400 in its research report dated November 01, 2020....

Laurus Labs Standalone September 2020 Net Sales at Rs 1,127.30 crore, up 59.71% Y-o-Y

6.33 pm | 02 Nov 2020 |  Source: Moneycontrol.com

NULL...

Buy Laurus Labs; target of Rs 385: Sharekhan

3.12 pm | 02 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 385 in its research report dated October 30, 2020....

Buy Laurus Labs; target of Rs 400: Motilal Oswal

12.54 pm | 02 Nov 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 400 in its research report dated October 30, 202...

Laurus Labs: Moves in to next growth orbit; accumulate

9.27 am | 02 Nov 2020 |  Source: Moneycontrol.com

Laurus Labs has gained 3.6X since we recommended it in July 2019. What should you do now?...

Laurus Labs Standalone September 2020 Net Sales at Rs 1,127.30 crore, up 59.71% Y-o-Y

9.11 am | 30 Oct 2020 |  Source: Moneycontrol.com

NULL...

Laurus Labs reports highest-ever quarterly profit at Rs 242 crore in Q2FY21

6.15 pm | 29 Oct 2020 |  Source: Moneycontrol.com

Revenues rose 60 percent YoY to Rs 1,139 crore in Q2FY21, compared to Rs 713.8 crore last year....

Buy Laurus Labs; target of Rs 1215: Motilal Oswal

1.43 pm | 07 Aug 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1215 in its research report dated August 01, 202...

Laurus Labs has gained 3X since we recommended it a year ago. What should you do now?

12.05 pm | 05 Aug 2020 |  Source: Moneycontrol.com

Laurus Labs' medium term plan is to increase API manufacturing capacity by 20 percent over 12 months and formulations capacity by 80 percent over ...

Laurus Labs Standalone June 2020 Net Sales at Rs 970.41 crore, up 79.29% Y-o-Y

9.33 am | 31 Jul 2020 |  Source: Moneycontrol.com

NULL...

Laurus Labs' net up 11 times to Rs 172 crore in Q1

5.35 pm | 30 Jul 2020 |  Source: PTI

Revenues from operations were up 77 percent during the quarter under discussion to Rs 974 crore, a press release said....

Laurus Labs' PAT touches Rs 110 crore in Q4

6.50 pm | 30 Apr 2020 |  Source: PTI

With higher volumes and new product introduction, our other API (active pharmaceutical ingredient) business segment has posted healthy growth, we do e...

Hot Stocks | Here are three short-term trading ideas

7.17 am | 22 Apr 2020 |  Source: Moneycontrol.com

On the technical front, 8,800 levels would act as a major support for Nifty below which we could see further long liquidation which could drag the ind...

Coronavirus: Laurus Labs to supply Hydroxychloroquine for clinical trials in the US

10.42 pm | 27 Mar 2020 |  Source: Moneycontrol.com

The company has received an approval from the US Food & Drug Administration (USFDA) to market Hydroxychloroquine Sulphate tablets...

Ideas for Profit | Laurus Labs Q3: Improving product mix a key catalyst 

9.17 am | 03 Mar 2020 |  Source: Moneycontrol.com

NULL...

Laurus Labs banking on vertical integration to crack anti-HIV tenders and US formulations mkts

8.30 pm | 25 Feb 2020 |  Source: Moneycontrol.com

The company has so far filed 24 abbreviated new drug applications (ANDAs) with US FDA. It has five final approvals, three tentative approvals and two ...

Laurus Labs Standalone December 2019 Net Sales at Rs 720.99 crore, up 40.61% Y-o-Y

12.30 pm | 31 Jan 2020 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Laurus Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.